FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 107 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is 6.48 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,415,000 | +400.0% | 321,553 | +72.6% | 0.00% | – |
| Q2 2022 | $1,283,000 | -46.7% | 186,342 | -28.0% | 0.00% | -100.0% |
| Q1 2022 | $2,406,000 | -38.0% | 258,736 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $3,880,000 | -14.0% | 272,853 | +40.3% | 0.00% | 0.0% |
| Q3 2021 | $4,511,000 | +10.7% | 194,545 | +18.8% | 0.00% | 0.0% |
| Q2 2021 | $4,076,000 | -19.6% | 163,735 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $5,068,000 | +20.3% | 180,886 | +49.9% | 0.00% | 0.0% |
| Q4 2020 | $4,212,000 | -6.2% | 120,698 | +25.0% | 0.00% | 0.0% |
| Q2 2020 | $4,491,000 | – | 96,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |